Scinai Immunotherapeutics SCNI
NASDAQ SCNI
$0.75 0.00 (-0.32%)
At close: Oct 19, 2026 · 4:00 PM EDT

Scinai Immunotherapeutics (SCNI) Operating Interest Expenses (2023 - 2024)

Updated

Analysis

Scinai Immunotherapeutics (SCNI) Operating Interest Expenses (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Interest Exp. (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn -
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn -
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn -
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn -
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn -
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn -
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn -
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn -
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn -
10 Scinai Immunotherapeutics 170,024.89 -8.10 Mn -1.25 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 295,000.00
Mar 31, 2024 231,000.00
Jun 30, 2023 1.17 Mn
Mar 31, 2023 329,000.00
API Access

Scinai Immunotherapeutics Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-interest-expenses&ticker=SCNI&period=max&api_key=YOUR_API_KEY